Relay Therapeutics, Inc.: cashflow_financing
| Value | {"amount": 5606000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | Relay Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8bb3c34e-881c-47f8-817d-ed5c663caa65
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-015518Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001812364/cashflow-financing/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8bb3c34e-881c-47f8-817d-ed5c663caa65
History
- no predecessors — first report